Zai Lab (ZLAB) Accumulated Expenses (2016 - 2020)
Zai Lab (ZLAB) posted Accumulated Expenses of $7.5 million for Q2 2020, down 21.57% sequentially from $9.6 million in Q4 2019.
Zai Lab (ZLAB) Accumulated Expenses (2016 - 2020) Analysis & Trends
Zai Lab has reported Accumulated Expenses for 5 years, with the latest figure at $7.5 million in Q2 2020.
- Quarterly Accumulated Expenses changed N/A year-over-year to $7.5 million in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $7.5 million (changed N/A YoY) and the FY2019 annual result came in at $9.6 million, up 159.26% from the prior year.
- Accumulated Expenses retreated to $7.5 million in Q2 2020 per ZLAB's latest filing, from $9.6 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $9.6 million in Q4 2019 and troughed at $573802.0 in Q4 2016.
- A 5-year average of $5.1 million and a median of $5.6 million in 2018 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2017 and 2018: Accumulated Expenses jumped 180.19% in 2017, then jumped 130.07% in 2018.
- Over 5 years, Accumulated Expenses stood at $573802.0 in 2016, then surged by 180.19% to $1.6 million in 2017, then surged by 130.07% to $3.7 million in 2018, then soared by 159.26% to $9.6 million in 2019, then slipped by 21.57% to $7.5 million in 2020.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $7.5 million, $9.6 million, and $7.7 million for Q2 2020, Q4 2019, and Q3 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 7.52 Mn |
| Dec 31, 2019 | 9.59 Mn |
| Sep 30, 2019 | 7.67 Mn |
| Dec 31, 2018 | 3.70 Mn |
| Dec 31, 2017 | 1.61 Mn |
| Dec 31, 2016 | 573,802.00 |